Further, mechanistic studies in ANCA-associated vasculitis identified CD28null T cells acting independently of the CD28/CD80 pathway, which may explain why CD80/CD86 inhibition in ANCA disease may not be optimal [13]. Here, CD86 is linked to anti-neutrophil cytoplasmic antibody-associated vasculitis.